Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis

Public Deposited
Analytics
Request Version for Screen Reader
Creator
  • Nurmatov,
    • Other Affiliation: Division of Population Medicine Neuadd Meirionnydd; School of Medicine; Cardiff University
  • Dhami,
    • ORCID: 0000-0002-2823-3258
    • Other Affiliation: Evidence-Based Health Care Ltd
  • Arasi,
    • Other Affiliation: Department of Pediatrics; Allergy Unit; University of Messina
  • Pajno,
    • Other Affiliation: Department of Pediatrics; Allergy Unit; University of Messina
  • Fernandez-Rivas,
    • Other Affiliation: Allergy Department; Hospital Clínico San Carlos; IdISSC
  • Muraro,
    • Other Affiliation: Department of Women and Child Health; Food Allergy Referral Centre Veneto Region; Padua General University Hospital
  • Roberts,
    • Other Affiliation: The David Hide Asthma and Allergy Research Centre; St Mary's Hospital; Newport
  • Akdis,
    • Other Affiliation: Swiss Institute for Allergy and Asthma Research
  • Alvaro-Lozano,
    • Other Affiliation: Paediatric Allergy and Clinical Immunology Section; Hospital Sant Joan de Déu; Universitat de Barcelona
  • Beyer,
    • Other Affiliation: Icahn School of Medicine at Mount Sinai
  • Bindslev-Jensen,
    • Other Affiliation: Department of Dermatology and Allergy Centre; Odense University Hospital
  • Burks,
  • du Toit,
    • Other Affiliation: Department of Paediatric Allergy; Division of Asthma; Allergy and Lung Biology; MRC & Asthma Centre in Allergic Mechanisms of Asthma; King's College London; St Thomas NHS Foundation Trust
  • Ebisawa,
    • Other Affiliation: Department of Allergy; Clinical Research Center for Allergy & Rheumatology; Sagamihara National Hospital
  • Eigenmann,
    • Other Affiliation: University Hospitals of Geneva and Medical School of the University of Geneva
  • Knol,
    • Other Affiliation: Department of Immunology and Department of Dermatology & Allergology; University Medical Center
  • Makela,
    • Other Affiliation: Skin and Allergy Hospital; Helsinki University Hospital
  • Nadeau,
    • ORCID: 0000-0002-2146-2955
    • Other Affiliation: Department of Pediatrics; Division of Immunology; Allergy and Rheumatology; Stanford University
  • O'Mahony,
    • ORCID: 0000-0003-4705-3583
    • Other Affiliation: Swiss Institute of Allergy and Asthma Research (SIAF); University of Zurich
  • Papadopoulos,
    • Other Affiliation: Department of Allergy; 2nd Pediatric Clinic; University of Athens
  • Poulsen,
    • Other Affiliation: Department of Allergy Clinic; Copenhagen University Hospital
  • Sackesen,
    • Other Affiliation: Department of Pediatric Allergist; Koç University Hospital
  • Sampson,
    • Other Affiliation: World Allergy Organization (WAO)
  • Santos,
    • Other Affiliation: Department of Paediatric Allergy; Division of Asthma; Allergy and Lung Biology; King's College London; Guy's and St Thomas’ Hospital NHS Foundation Trust
  • van Ree,
    • Other Affiliation: Department of Otorhinolaryngology; Academic Medical Center
  • Timmermans,
    • Other Affiliation: Nederlands Anafylaxis Netwerk – European Anaphylaxis Taskforce
  • Sheikh,
    • Other Affiliation: Allergy and Respiratory Research Group; Centre of Medical Informatics; Usher Institute of Population Health Sciences and Informatics; The University of Edinburgh
Abstract
  • BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated Food Allergy. To inform the development of clinical recommendations, we sought to critically assess evidence on the effectiveness, safety and cost-effectiveness of AIT in the management of food allergy. METHODS: We undertook a systematic review and meta-analysis that involved searching nine international electronic databases for randomized controlled trials (RCTs) and nonrandomized studies (NRS). Eligible studies were independently assessed by two reviewers against predefined eligibility criteria. The quality of studies was assessed using the Cochrane Risk of Bias tool for RCTs and the Cochrane ACROBAT-NRS tool for quasi-RCTs. Random-effects meta-analyses were undertaken, with planned subgroup and sensitivity analyses. RESULTS: We identified 1814 potentially relevant papers from which we selected 31 eligible studies, comprising of 25 RCTs and six NRS, studying a total of 1259 patients. Twenty-five trials evaluated oral immunotherapy (OIT), five studies investigated sublingual immunotherapy, and one study evaluated epicutaneous immunotherapy. The majority of these studies were in children. Twenty-seven studies assessed desensitization, and eight studies investigated sustained unresponsiveness postdiscontinuation of AIT. Meta-analyses demonstrated a substantial benefit in terms of desensitization (risk ratio (RR) = 0.16, 95% CI 0.10, 0.26) and suggested, but did not confirm sustained unresponsiveness (RR = 0.29, 95% CI 0.08, 1.13). Only one study reported on disease-specific quality of life (QoL), which reported no comparative results between OIT and control group. Meta-analyses revealed that the risk of experiencing a systemic adverse reaction was higher in those receiving AIT, with a more marked increase in the risk of local adverse reactions. Sensitivity analysis excluding those studies judged to be at high risk of bias demonstrated the robustness of summary estimates of effectiveness and safety of AIT for food allergy. None of the studies reported data on health economic analyses. CONCLUSIONS: AIT may be effective in raising the threshold of reactivity to a range of foods in children with IgE-mediated food allergy whilst receiving (i.e. desensitization) and post-discontinuation of AIT. It is, however, associated with a modest increased risk in serious systemic adverse reactions and a substantial increase in minor local adverse reactions. More data are needed in relation to adults, long term effects, the impact on QoL and the cost-effectiveness of AIT.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • Allergy
Journal volume
  • 72
Journal issue
  • 8
Page start
  • 1133
Page end
  • 1147
Language
  • English
ISSN
  • 1398-9995
  • 0105-4538

Relations

Parents:

This work has no parents.

Items